Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of AMG 479 With Biologics or Chemotherapy in Adult Subjects With Advanced Solid Tumors

NCT00974896 is registered in ClinicalTrials.gov with NantCell, Inc. as lead sponsor.

NCT NCT00974896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00974896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of AMG 479 With Biologics or Chemotherapy in Adult Subjects With Advanced Solid Tumors
Lead sponsor
NantCell, Inc.
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2006
Completion date
April 30, 2011
Enrollment
46 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignancy, advanced solid tumors, cancer, solid tumors, tumors